Holen Sie sich die Stockscreener-App
1.405
0.04%
-0.005
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HRTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.40
Offen:
$1.4
24-Stunden-Volumen:
590.11K
Relative Volume:
0.39
Marktkapitalisierung:
$215.37M
Einnahmen:
$137.74M
Nettoeinkommen (Verlust:
$-27.97M
KGV:
-8.7813
EPS:
-0.16
Netto-Cashflow:
$-9.61M
1W Leistung:
+7.65%
1M Leistung:
-26.73%
6M Leistung:
-16.70%
1J Leistung:
-28.23%
1-Tages-Spanne:
$1.39
$1.42
1-Wochen-Bereich:
$1.25
$1.42
52-Wochen-Spanne:
$1.04
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Firmenname
Heron Therapeutics Inc
Sektor
Branche
Telefon
(858) 251-4400
Adresse
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Vergleichen Sie HRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.405 | 199.28M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.31 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.07 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.04 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
692.03 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
314.64 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-23 | Eingeleitet | CapitalOne | Overweight |
| 2024-03-13 | Bestätigt | Needham | Buy |
| 2020-05-27 | Eingeleitet | Guggenheim | Buy |
| 2020-02-20 | Bestätigt | Needham | Buy |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-04-05 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2018-03-01 | Bestätigt | Needham | Buy |
| 2018-01-03 | Eingeleitet | Leerink Partners | Outperform |
| 2017-09-27 | Eingeleitet | Northland Capital | Outperform |
| 2017-02-27 | Eingeleitet | Needham | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-09-06 | Fortgesetzt | Lake Street | Buy |
| 2016-05-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-12-10 | Eingeleitet | Lake Street | Buy |
| 2015-09-23 | Bestätigt | Leerink Partners | Outperform |
| 2015-09-02 | Eingeleitet | BofA/Merrill | Buy |
| 2015-08-03 | Bestätigt | Brean Capital | Buy |
| 2015-06-30 | Bestätigt | JMP Securities | Mkt Outperform |
| 2015-06-19 | Bestätigt | Leerink Partners | Outperform |
| 2014-08-07 | Eingeleitet | Noble Financial | Buy |
Alle ansehen
Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten
Sector Rotation Brings Heron Therapeutics Inc. Into Focus2025 Winners & Losers & Accurate Entry/Exit Alerts - newsyoung.net
Technical Models Detect Momentum Build in Heron Therapeutics Inc.Weekly Trade Review & Fast Gain Swing Trade Alerts - classian.co.kr
Heron Therapeutics Inc. Stages Intraday Comeback — Trend Change2025 AllTime Highs & Trade Opportunity Analysis Reports - newsyoung.net
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by Zacks Research - MarketBeat
Heron Therapeutics Inc. Facing Inflection Point in Trend AnalysisJuly 2025 Patterns & Smart Investment Allocation Tips - newsyoung.net
Can Traders Expect Breakout From Heron Therapeutics Inc. This WeekJuly 2025 Chart Watch & Expert Approved Momentum Ideas - 선데이타임즈
XTX Topco Ltd Sells 213,080 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Adam Morgan Acquires 1,766,546 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock - MarketBeat
Heron Therapeutics Adopts Tax Benefit Preservation Plan - MSN
Informed Momentum Co LLC Takes $768,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Tick level data insight on Heron Therapeutics Inc. volatilityMarket Growth Report & Technical Entry and Exit Alerts - Newser
Will Heron Therapeutics Inc. outperform the marketJuly 2025 PostEarnings & Weekly Market Pulse Alerts - Newser
Heron Therapeutics, Inc. (NASDAQ:HRTX) Major Shareholder Rubric Capital Management Lp Buys 2,387,225 Shares - MarketBeat
Heron Therapeutics Inc. stock trendline breakdownJuly 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
How to build a dashboard for Heron Therapeutics Inc. stockTrade Analysis Summary & Community Verified Swing Trade Signals - Newser
Is Heron Therapeutics Inc. undervalued by DCF analysisRecession Risk & Entry Point Confirmation Signals - newsyoung.net
Using portfolio simulators with Heron Therapeutics Inc. includedJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Heron Therapeutics Inc. stock volume spike explainedJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Technical analysis overview for Heron Therapeutics Inc. stockPortfolio Value Report & Verified Chart Pattern Signals - Newser
Custom strategy builders for tracking Heron Therapeutics Inc.Quarterly Trade Summary & Long-Term Safe Return Strategies - Newser
Strategic Tax Preservation as a Catalyst for Long-Term Value Creation: Heron Therapeutics' Section 382 Rights Plan and Its Implications for Biotech Investors - AInvest
Heron Therapeutics Adopts Rights Plan to Protect Tax Benefits - MarketScreener
Heron Therapeutics adopts tax benefits preservation plan - TipRanks
Strategic Tax Planning as a Catalyst for Shareholder Value: Heron Therapeutics' Section 382 Rights Plan - AInvest
Heron Therapeutics adopts tax benefits plan to protect $1.37 billion in NOLs - Investing.com
$1.37 Billion Tax Asset Protection: Heron Therapeutics Adopts Strategic Rights Plan to Preserve NOLs - Stock Titan
Will Heron Therapeutics Inc. face regulatory challengesJuly 2025 Intraday Action & Safe Capital Investment Plans - newsyoung.net
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2025 Earnings Call Transcript - MSN
Heron Therapeutics (NASDAQ:HRTX) Announces Quarterly Earnings Results - MarketBeat
DLA Piper advises Heron Therapeutics in comprehensive capital financings - DLA Piper
Heron Therapeutics Signs Agreement with Patheon - MSN
Heron Therapeutics’ Earnings Call Highlights Growth and Strategy - TipRanks
Published on: 2025-08-14 05:28:34 - Newser
XTX Topco Ltd Sells 213,080 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Needham & Company LLC Cuts Heron Therapeutics (NASDAQ:HRTX) Price Target to $3.00 - MarketBeat
Heron Therapeutics Strengthens Financial Position with Refinancing - MSN
Heron Therapeutics (NASDAQ:HRTX) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Warner Bros Discovery Director Buys $3.55M Worth of WBD Shares, Heron Therapeutics Director Purchases $2.65M Worth of HRTX Shares - AInvest
Heron Therapeutics Soars 13.74% on Insider Buying, Strategic Moves - AInvest
Rubric Capital and Director Morgan Make Significant Investments in Heron Therapeutics - AInvest
Heron Therapeutics Strengthens Financial Position with Refinancing and Board Changes - AInvest
Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Heron Therapeutics Inc-Aktie (HRTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
0.39%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):